DOCS vs. TMO: A Head-to-Head Stock Comparison
Updated onHere’s a clear look at DOCS and TMO, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.
Company Profile
| Symbol | DOCS | TMO |
|---|---|---|
| Company Name | Doximity, Inc. | Thermo Fisher Scientific Inc. |
| Country | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry | Health Care Technology | Life Sciences Tools & Services |
| Market Capitalization | 13.72 billion USD | 205.16 billion USD |
| Exchange | NYSE | NYSE |
| Listing Date | June 24, 2021 | March 17, 1980 |
| Security Type | Common Stock | Common Stock |
Historical Performance
This chart compares the performance of DOCS and TMO by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.
Historical Performance at a Glance
| Symbol | DOCS | TMO |
|---|---|---|
| 5-Day Price Return | -3.24% | 17.59% |
| 13-Week Price Return | 21.38% | 26.55% |
| 26-Week Price Return | 23.04% | 9.19% |
| 52-Week Price Return | 66.64% | -11.33% |
| Month-to-Date Return | -1.59% | 12.02% |
| Year-to-Date Return | 34.84% | 4.44% |
| 10-Day Avg. Volume | 1.73M | 3.29M |
| 3-Month Avg. Volume | 1.70M | 2.56M |
| 3-Month Volatility | 41.97% | 38.81% |
| Beta | 1.39 | 0.88 |
Profitability
Return on Equity (TTM)
DOCS
22.94%
Health Care Technology Industry
- Max
- 48.09%
- Q3
- 41.80%
- Median
- 18.17%
- Q1
- 11.64%
- Min
- 11.05%
DOCS’s Return on Equity of 22.94% is on par with the norm for the Health Care Technology industry, indicating its profitability relative to shareholder equity is typical for the sector.
TMO
13.27%
Life Sciences Tools & Services Industry
- Max
- 19.96%
- Q3
- 11.51%
- Median
- 6.47%
- Q1
- 3.86%
- Min
- -6.95%
In the upper quartile for the Life Sciences Tools & Services industry, TMO’s Return on Equity of 13.27% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.
Net Profit Margin (TTM)
DOCS
39.88%
Health Care Technology Industry
- Max
- 52.24%
- Q3
- 49.15%
- Median
- 33.59%
- Q1
- 16.86%
- Min
- 13.38%
DOCS’s Net Profit Margin of 39.88% is aligned with the median group of its peers in the Health Care Technology industry. This indicates its ability to convert revenue into profit is typical for the sector.
TMO
15.23%
Life Sciences Tools & Services Industry
- Max
- 32.18%
- Q3
- 18.30%
- Median
- 10.19%
- Q1
- 4.20%
- Min
- -2.05%
TMO’s Net Profit Margin of 15.23% is aligned with the median group of its peers in the Life Sciences Tools & Services industry. This indicates its ability to convert revenue into profit is typical for the sector.
Operating Profit Margin (TTM)
DOCS
40.07%
Health Care Technology Industry
- Max
- 74.05%
- Q3
- 65.56%
- Median
- 33.50%
- Q1
- 22.83%
- Min
- 21.46%
DOCS’s Operating Profit Margin of 40.07% is around the midpoint for the Health Care Technology industry, indicating that its efficiency in managing core business operations is typical for the sector.
TMO
17.13%
Life Sciences Tools & Services Industry
- Max
- 38.39%
- Q3
- 21.40%
- Median
- 13.57%
- Q1
- 8.38%
- Min
- -3.51%
TMO’s Operating Profit Margin of 17.13% is around the midpoint for the Life Sciences Tools & Services industry, indicating that its efficiency in managing core business operations is typical for the sector.
Profitability at a Glance
| Symbol | DOCS | TMO |
|---|---|---|
| Return on Equity (TTM) | 22.94% | 13.27% |
| Return on Assets (TTM) | 19.76% | 6.62% |
| Net Profit Margin (TTM) | 39.88% | 15.23% |
| Operating Profit Margin (TTM) | 40.07% | 17.13% |
| Gross Profit Margin (TTM) | 90.14% | 41.34% |
Financial Strength
Current Ratio (MRQ)
DOCS
6.47
Health Care Technology Industry
- Max
- 6.49
- Q3
- 6.49
- Median
- 6.02
- Q1
- 3.62
- Min
- 2.96
DOCS’s Current Ratio of 6.47 aligns with the median group of the Health Care Technology industry, indicating that its short-term liquidity is in line with its sector peers.
TMO
1.93
Life Sciences Tools & Services Industry
- Max
- 3.46
- Q3
- 2.78
- Median
- 1.91
- Q1
- 1.53
- Min
- 0.43
TMO’s Current Ratio of 1.93 aligns with the median group of the Life Sciences Tools & Services industry, indicating that its short-term liquidity is in line with its sector peers.
Debt-to-Equity Ratio (MRQ)
DOCS
0.00
Health Care Technology Industry
- Max
- 0.14
- Q3
- 0.10
- Median
- 0.01
- Q1
- 0.00
- Min
- 0.00
Falling into the lower quartile for the Health Care Technology industry, DOCS’s Debt-to-Equity Ratio of 0.00 points to a conservative financing strategy. This results in lower financial risk but potentially limits strategic investments compared to more leveraged competitors.
TMO
0.70
Life Sciences Tools & Services Industry
- Max
- 1.35
- Q3
- 0.74
- Median
- 0.41
- Q1
- 0.18
- Min
- 0.00
TMO’s Debt-to-Equity Ratio of 0.70 is typical for the Life Sciences Tools & Services industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
Interest Coverage Ratio (TTM)
DOCS
--
Health Care Technology Industry
- Max
- 224.12
- Q3
- 224.12
- Median
- 219.00
- Q1
- 219.00
- Min
- 219.00
Interest Coverage Ratio data for DOCS is currently unavailable.
TMO
23.55
Life Sciences Tools & Services Industry
- Max
- 45.00
- Q3
- 27.84
- Median
- 7.16
- Q1
- 2.12
- Min
- -14.08
TMO’s Interest Coverage Ratio of 23.55 is positioned comfortably within the norm for the Life Sciences Tools & Services industry, indicating a standard and healthy capacity to cover its interest payments.
Financial Strength at a Glance
| Symbol | DOCS | TMO |
|---|---|---|
| Current Ratio (MRQ) | 6.47 | 1.93 |
| Quick Ratio (MRQ) | 6.20 | 1.50 |
| Debt-to-Equity Ratio (MRQ) | 0.00 | 0.70 |
| Interest Coverage Ratio (TTM) | -- | 23.55 |
Growth
Revenue Growth
EPS Growth
Dividend
Dividend Yield (TTM)
DOCS
0.00%
Health Care Technology Industry
- Max
- 0.89%
- Q3
- 0.70%
- Median
- 0.15%
- Q1
- 0.04%
- Min
- 0.00%
DOCS currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.
TMO
0.30%
Life Sciences Tools & Services Industry
- Max
- 1.41%
- Q3
- 0.65%
- Median
- 0.35%
- Q1
- 0.00%
- Min
- 0.00%
TMO’s Dividend Yield of 0.30% is consistent with its peers in the Life Sciences Tools & Services industry, providing a dividend return that is standard for its sector.
Dividend Payout Ratio (TTM)
DOCS
0.00%
Health Care Technology Industry
- Max
- 101.92%
- Q3
- 87.10%
- Median
- 42.63%
- Q1
- 10.66%
- Min
- 0.00%
DOCS has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.
TMO
9.27%
Life Sciences Tools & Services Industry
- Max
- 113.14%
- Q3
- 61.34%
- Median
- 17.74%
- Q1
- 0.00%
- Min
- 0.00%
TMO’s Dividend Payout Ratio of 9.27% is within the typical range for the Life Sciences Tools & Services industry, suggesting a balanced approach between shareholder payouts and company reinvestment.
Dividend at a Glance
| Symbol | DOCS | TMO |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.30% |
| Dividend Payout Ratio (TTM) | 0.00% | 9.27% |
Valuation
Price-to-Earnings Ratio (TTM)
DOCS
58.36
Health Care Technology Industry
- Max
- 280.41
- Q3
- 225.12
- Median
- 59.01
- Q1
- 44.08
- Min
- 39.20
DOCS’s P/E Ratio of 58.36 is within the middle range for the Health Care Technology industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
TMO
30.86
Life Sciences Tools & Services Industry
- Max
- 75.35
- Q3
- 51.00
- Median
- 32.93
- Q1
- 25.27
- Min
- 1.43
TMO’s P/E Ratio of 30.86 is within the middle range for the Life Sciences Tools & Services industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
Price-to-Sales Ratio (TTM)
DOCS
23.27
Health Care Technology Industry
- Max
- 146.49
- Q3
- 115.78
- Median
- 19.83
- Q1
- 7.94
- Min
- 5.25
DOCS’s P/S Ratio of 23.27 aligns with the market consensus for the Health Care Technology industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
TMO
4.70
Life Sciences Tools & Services Industry
- Max
- 10.49
- Q3
- 6.43
- Median
- 4.66
- Q1
- 2.88
- Min
- 1.08
TMO’s P/S Ratio of 4.70 aligns with the market consensus for the Life Sciences Tools & Services industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
Price-to-Book Ratio (MRQ)
DOCS
11.22
Health Care Technology Industry
- Max
- 115.01
- Q3
- 89.07
- Median
- 9.11
- Q1
- 4.04
- Min
- 3.06
DOCS’s P/B Ratio of 11.22 is within the conventional range for the Health Care Technology industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.
TMO
3.03
Life Sciences Tools & Services Industry
- Max
- 6.69
- Q3
- 5.00
- Median
- 3.46
- Q1
- 2.38
- Min
- 0.93
TMO’s P/B Ratio of 3.03 is within the conventional range for the Life Sciences Tools & Services industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.
Valuation at a Glance
| Symbol | DOCS | TMO |
|---|---|---|
| Price-to-Earnings Ratio (TTM) | 58.36 | 30.86 |
| Price-to-Sales Ratio (TTM) | 23.27 | 4.70 |
| Price-to-Book Ratio (MRQ) | 11.22 | 3.03 |
| Price-to-Free Cash Flow Ratio (TTM) | 47.76 | 32.92 |